The Ghana-based health-tech company, MedPharama, has been selected as a beneficiary of the pan-African business support initiative Investing in Innovation (i3).
Founded by Stephen Yaw Asamoah in 2016, MedPharma is a tech-health social impact enterprise seeking to improve the health status of patients across Africa. Medpharma provides e-consultation, e-prescription, delivery of medicines and medical equipment, diagnostics, and storage of medical records through their mobile application, website, chatbot, and hotline platforms.
i3, funded by the Bill & Melinda Gates Foundation and sponsored by Merck Sharp & Dohme (MSD), the World Health Organization Regional Office for Africa, AUDA-NEPAD, and AmerisourceBergen, is an initiative to support the commercialization and impact promising early & growth-stage health tech companies with grants and access to market support.
The selected startups will receive a $50,000 grant and support to catalyze growth-driven partnerships with donors, industry, and institutions. Startups will also receive investment readiness support from CcHub for West Africa, Startupbootcamp AfriTech for Southern Africa, IMPACT Lab for North and Francophone Africa, and Villgro Africa for East Africa.
